Fishon v. Premier Nutrition Corporation
Filing
231
ORDER ON ADDITIONAL MOTIONS IN LIMINE. Signed by Chief Judge Richard Seeborg on 5/19/2022. (rslc3, COURT STAFF) (Filed on 5/19/2022)
1
2
3
4
5
6
UNITED STATES DISTRICT COURT
7
NORTHERN DISTRICT OF CALIFORNIA
8
9
10
MARY BETH MONTERA,
Case No. 16-cv-06980-RS
Plaintiff,
11
United States District Court
Northern District of California
v.
ORDER ON ADDITIONAL MOTIONS
IN LIMINE
12
13
PREMIER NUTRITION CORPORATION,
Defendant.
14
15
16
17
I. Introduction
In this consumer class action alleging violations of New York false advertising law, Lead
18
Plaintiff Mary Beth Montera and Defendant Premier Nutrition Corporation (“Premier”) each bring
19
an additional motion in limine in advance of the May 23, 2022 trial. Plaintiff’s motion to exclude
20
evidence and argument concerning Premier’s affirmative defense is denied. Defendant’s motion to
21
exclude evidence and argument concerning alleged omissions on the Joint Juice label is granted
22
concerning argument on an omissions-based theory of liability, but Plaintiff may nonetheless
23
present evidence about what information or statements were not included on the Joint Juice label.
24
25
II. Plaintiff’s Motion in Limine
Plaintiff brings a motion to preclude evidence and argument regarding Premier’s
26
affirmative defense of compliance with FDA regulations and requests an offer of proof pursuant to
27
Federal Rule of Evidence 104. The order addressing Plaintiff’s earlier motion to exclude evidence
28
and argument concerning FDA drug or supplement standards stated that “Defendant is entitled to
United States District Court
Northern District of California
1
present a safe harbor defense.” Order on Motions in Limine, p.2. It is a separate question, however
2
whether Defendant will be able to put forth adequate evidence to require submission of this
3
affirmative defense to the jury. Plaintiff argues that Defendant cannot satisfy the legal
4
prerequisites to establish a safe harbor defense. In particular, Plaintiff argues that Defendant was
5
not in compliance with federal regulations because it did not give notice of its structure/function
6
statement on the label within 30 days, as required by statute. See 21 U.S.C. § 343(r)(6)(C) (“If the
7
manufacturer of a dietary supplement proposes to make a [structure/function] statement described
8
in the first sentence of this subparagraph in the labeling of the dietary supplement, the
9
manufacturer shall notify the Secretary no later than 30 days after the first marketing of the dietary
10
supplement with such statement that such a statement is being made.”). Defendant does not
11
contest that it did not provide notice within 30 days of the first marketing; instead, Defendant
12
appears to argue—without citing any authority—that notification before the beginning of the class
13
period in this case somehow suffices to satisfy the statute’s requirement. Plaintiff’s motion to
14
preclude evidence of the defense is denied, but Plaintiff may renew her argument that there is
15
insufficient evidence to support the affirmative defense at the close of evidence when decisions on
16
final jury instructions are made.1
III. Defendant’s Motion in Limine
17
Defendant brings a motion in limine to exclude evidence and argument that Joint Juice’s
18
19
label is deceptive or misleading under New York law because of omissions from the label.
20
Plaintiff has proposed jury instructions which would instruct the jury to consider both claims on
21
the label and omissions. As Defendant notes, the joint health claims on the Joint Juice label have
22
always been the core of this litigation. Plaintiff argues that evidence and instruction on omissions
23
is appropriate because there is reference to omissions in her operative complaint, and that
24
25
26
27
1
It is also noted that evidence concerning FDA standards for dietary supplements is relevant to the
context in which Premier developed marketing and advertising for Joint Juice, and thus the type of
evidence Plaintiff seeks to exclude would be admissible even if Defendant was not allowed to
pursue a safe harbor defense.
ORDER ON ADDITIONAL MOTIONS IN LIMINE
CASE NO. 16-cv-06980-RS
28
2
1
omissions are intertwined with her theory of liability concerning affirmative misrepresentations.
2
Instructing the jury on the omission theory, however, is inappropriate when this case has
3
proceeded through litigation—including class certification—with a focus on the statements on the
4
Joint Juice label. Plaintiffs may present evidence regarding omissions because the question of
5
what was not on the Joint Juice label is intertwined with the question of what was on the label, but
6
instructing the jury on an omissions theory of liability is inappropriate and risks confusing the jury
7
as to the core question in this litigation: whether the statements on the Joint Juice label are
8
deceptive and misleading.
IV. Conclusion
9
10
The motions in limine are denied and granted as described above.
United States District Court
Northern District of California
11
12
IT IS SO ORDERED.
13
14
15
16
Dated: May 19, 2022
______________________________________
RICHARD SEEBORG
Chief United States District Judge
17
18
19
20
21
22
23
24
25
26
27
ORDER ON ADDITIONAL MOTIONS IN LIMINE
CASE NO. 16-cv-06980-RS
28
3
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?